Chemists in the College of Arts and Sciences have figured out how to turn bacterial molecules into potential drug molecules.
Yan-Yeung Luk, associate professor of chemistry, and his research team have published their findings in ChemBioChem (John Wiley & Sons, 2015), explaining how they have created molecules that mimic and dominate toxic ones secreted by bacteria.
The implications for the study of biology and pharmacology are said to be enormous.
“Using toxic molecules to develop therapeutic agents, such as a vaccine, is not easy,” says Luk, who works at the interface of organic chemistry and the life sciences. “We’re just beginning to understand how some molecules—synthetic or naturally occurring—control the activities of bacteria. This will help us develop, among other things, drugs with many different applications.”
The Luk Research Group is focusing its attention on Pseudomonas aeruginosa, a microbe that causes many diseases and illnesses, including cystic fibrosis. Like other bacteria, P. aeruginosa produces a range of molecules that guides various activities. Among these molecules are rhamnolipids, which are made up of rhamnose sugar rings and fatty acids, and are able to reduce the surface tension of water. While rhamnolipids have been studied for decades, scientists don’t really know how they affect bacterial behavior.
Enter Luk, who, along with his research team, designs molecules that control such behavior. Their latest creation is a class of molecules called synthetic disaccharide derivatives (DSDs), which take over the chemical signaling of rhamnolipids to control activities such as biofilm formation, bacterial adhesion and swarming motility.
Lead author Nischal Singh G’15 and the rest of the Luk team have also discovered a subset of DSDs that dominates the function of rhamnolipids, and has demonstrated capacity for a range of new, unexpected bioactivities. The latter includes phenotypic switching, in which bacteria abandon their original phenotypes to “change” into two different phenotypes, and bacterial adhesion, considered the first step in colonization and biofilm formation.
“Biologists know how rhamnopilids are made by bacteria, and can knock out their production, but they don’t fully understand how rhamnolipids work—specifically, how they control different types of bacterial activities,” Luk says.
In addition to being non-toxic and biodegradable, rhamnolipids can withstand extreme temperatures, salinity and acidity. As a result, they have many useful chemical and biological properties.
Luk says that developing rhamnolipids into therapeutic agents has been speculated about for years, but without successful results. He hopes his group’s synthetic rhamnolipids approach is the exception. After designing and synthesizing two chemical libraries, or collections, of molecules, Luk’s third one contained two DSDs whose structures dominated the functions of rhamnolipids, offering the potential for many applications. It is from these two molecules that Luk’s team is making new ones.
The Latest on: Rhamnolipids
via Google News
The Latest on: Rhamnolipids
- UNC breakthrough could be key in battle against antibiotic resistanceon August 20, 2019 at 5:09 am
A new study out of the university, published in Cell Chemical Biology, has demonstrated that adding certain molecules – called rhamnolipids – can make existing antibiotics literally hundreds of times ...
- Antibiotic Resistance Thwarted with Biosurfactanton August 16, 2019 at 5:13 am
Pseudomonas aeruginosa-produced rhamnolipids target the plasma membrane of Staphylococcus aureus (labeled here in red) to increase permeability to aminoglycoside antibiotics. [Conlon Lab, UNC School ...
- Scientists find a potent weapon against antibiotic resistanceon August 15, 2019 at 7:44 am
In the study, the researchers discovered that incorporating molecules dubbed as rhamnolipids can make certain antibiotics a hundred times more powerful against Staphylococcus aureus, which causes many ...
- Characterization of rhamnolipids produced by an Arctic marine bacterium from the Pseudomonas fluorescence groupon July 30, 2018 at 7:38 am
The marine environment is a rich source of biodiversity, including microorganisms that have proven to be prolific producers of bioactive secondary metabolites. Arctic seas are less explored than ...
- Rhamnolipid Market Plan, Supply and Revenue to 2024on April 2, 2018 at 11:44 pm
Increasing demand for biosurfactants due to their rising application in agriculture, detergents, and oil & gas industries is expected to drive growth of the rhamnolipids market in the near future. Oil ...
- The production of rhamnolipid biosurfactant by Pseudomonas aeruginosa growing in biofilms.on January 30, 2018 at 3:57 pm
However, P. aeruginosa is a human pathogen and the rhamnolipids also play an important role in pathogenicity including the development of biofilms. Most of the research on production of the ...
- Investigation of the diversity and role of rhamnosyltransferase enzymes in rhamnolipid synthesis in bacteria.on January 30, 2018 at 3:57 pm
Rhamnolipids have been identified as microbial biosurfactants with huge potential for industrial exploitation, however, the best known producer, Pseudomonas aeruginosa is a human pathogen and ...
- Biosurfactants Market, 2022 - Increasing Demand for Green Solutionson January 2, 2018 at 10:00 am
The "Biosurfactants Market by Type (Glycolipids (Sophorolipids, Rhamnolipids), Lipopeptides, Phospholipids, Polymeric Biosurfactants), Application (Detergents, Personal Care, Agricultural Chemicals, ...
- Biosurfactants Market Worth 5.52 Billion USD by 2022on December 14, 2017 at 3:37 am
PUNE, India, December 14, 2017 /PRNewswire via COMTEX/ -- PUNE, India, December 14, 2017 /PRNewswire/ -- The report "Biosurfactants Market by Type (Glycolipids (Sophorolipids, Rhamnolipids), ...
- Sodium chloride effect on the aggregation behaviour of rhamnolipids and their antifungal activityon October 9, 2017 at 5:00 pm
Table 1 Growth inhibition percentages obtained for Aspergillus niger MUM 92.13 with the crude rhamnolipid mixture produced by Pseudomonas aeruginosa #112. The assays were performed at different ...
via Bing News